GPT Healthcare Limited, a key healthcare provider in Eastern India, announced its unaudited financial results for the third quarter and nine months ending December 31, 2025, during its board meeting on February 2, 2026. For the quarter ended December 31, 2025 (Q3 FY26), the company reported a total income of ₹121.20 Crores, representing a significant year-on-year (YoY) increase of 16.44% from ₹104.09 Crores in the corresponding quarter of the previous year. On a quarter-on-quarter (QoQ) basis, revenue grew by 0.79% from ₹120.25 Crores in Q2 FY26. The company’s net profit for the quarter stood at ₹13.20 Crores, showing an 7.76% YoY growth compared to ₹12.25 Crores in Q3 FY25 and a 24.53% QoQ increase from ₹10.60 Crores in the previous quarter.

GPT Healthcare Limited operates a chain of multispecialty tertiary care hospitals under the “ILS Hospitals” brand, primarily serving the under-penetrated markets of Eastern India. In May 2025, the company achieved a major milestone by fully commissioning its greenfield quaternary care hospital in Raipur, Chhattisgarh, featuring 158 beds. Furthering its growth strategy, the company signed a Memorandum of Understanding (MOU) in late 2025 for a new 150-bed hospital in Jamshedpur with an estimated investment of ₹70 Crores. The company is actively pursuing its target of expanding to a 1,000-bed capacity within the next two years, focusing on Tier I and Tier II cities. Prominent institutional investors in the company include the Bandhan Small Cap Fund, which holds approximately 4.72% of the equity, and the India Capital Growth Fund Limited, with a 2.68% stake.